ID: ALA157639

Max Phase: Preclinical

Molecular Formula: C14H17N5O4

Molecular Weight: 319.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(OCCCNc2nc(N)nc(O)c2N=O)cc1

Standard InChI:  InChI=1S/C14H17N5O4/c1-22-9-3-5-10(6-4-9)23-8-2-7-16-12-11(19-21)13(20)18-14(15)17-12/h3-6H,2,7-8H2,1H3,(H4,15,16,17,18,20)

Standard InChI Key:  AUZQQZSJWLADNX-UHFFFAOYSA-N

Associated Targets(non-human)

Dihydropteroate synthase 129 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.32Molecular Weight (Monoisotopic): 319.1281AlogP: 2.05#Rotatable Bonds: 8
Polar Surface Area: 131.95Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.91CX Basic pKa: 2.83CX LogP: 2.53CX LogD: 2.53
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.50Np Likeness Score: -0.74

References

1. Lever OW, Bell LN, Hyman C, McGuire HM, Ferone R..  (1986)  Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.,  29  (5): [PMID:3486292] [10.1021/jm00155a014]

Source